GSK2022-A L2WS 2021

Description: L2WS (L2 Written Summary) 2021 is a corpus containing 1 source text and 40 student summaries manually segmented in Idea Units. The source text is an expository text with problem solution structures embedded in it. The summaries were written by 40 undergraduate students at a university in Japan. They were all non-native speakers of English.
The summaries were collected as part of an assignment for an academic writing course in which the students were asked to read the source text (391 words) and summarise its main ideas and key details in approximately 80 words.
Please check README for more details.
Creator:Dr. Yasuyo SAWAKI (Waseda University)
Price: Limited to academic pursuits.
GSK Members can use the “Free Limited Distribution Language Resource to GSK Members” Service completely free of charge, limited to one time throughout a given year. In the event that a member uses this service for any “Free Limited Distribution Language Resource for GSK Members” more than once during any given year, a charge of 5,500 yen per incident (excluding shipping fees and applicable taxes) will be assessed. A sum of 33,000 yen (including shipping fees and applicable taxes) will be charged per incident for non-members.
Free Limited Distribution Language Resources for GSK Members
In the case of overseas delivery, it shall be determined case by case.
Date:2022.8
Format:Zip file (152KB)
Format.encoding:UTF-8
Language:English

For acquiring the above language resource, fill out all necessary items on the Application for and Compliance of Use Form (for above resource only), and send to our office via email, fax, or postal service. We will send documents including the billing statement through return mail. Please insure the proper billing address is indicated on the application, if different from your address. Also make sure to reference our page on “Membership and Usage Types for Individuals and Groups” concerning the Application for and Compliance of Use Form.
We will send you the language resource via email.